Inflammation is vital for host defence against invasive pathogens. In response to an infection, a cascade of signals leads to the recruitment of inflammatory cells, particularly innate immune cells such as neutrophils and macrophages. These cells, in turn, phagocytose infectious agents and produce additional cytokines and chemokines that lead to the activation of lympho cytes and adaptive immune responses. Similar to the eradication of pathogens, the inflammatory response is also crucial for tissue and wound repair
. Inflammation as a result of trauma, ischaemiareperfusion injury or chemically induced injury typically occurs in the absence of any microorganisms and has therefore been termed 'sterile inflammation' . Similar to microbially induced inflammation, sterile inflamma tion is marked by the recruitment of neutrophils and macrophages and the production of proinflammatory cytokines and chemokines, notably tumour necrosis factor (TNF) and interleukin1 (IL1).
Although inflammation is important in tissue repair and eradication of harmful pathogens, unresolved, chronic inflammation that occurs when the offending agent is not removed or contained can be detrimental to the host. The production of reactive oxygen species (ROS), proteases and growth factors by neutrophils and macrophages results in tissue destruction, as well as fibroblast proliferation, aberrant collagen accumulation and fibrosis. There are several examples of sterile inflam matory diseases. Chronic inhalation of sterile irritants, such as asbestos and silica, can lead to persistent activa tion of alveolar macrophages and result in pulmonary interstitial fibrosis 1 . In ischaemia-reperfusion injury, as seen with myocardial infarction and stroke, the restoration of blood flow causes further tissue destruction as a result of neutrophilic infiltration, enhanced production of ROS and inflammatory responses to necrotic cells 2 . Sterile inflammation has also been implicated in such disease processes as gout and pseudogout, in which the deposition of monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) crystals in the joints results in acute neutrophilic infiltration followed by chronic inflammation, fibrosis and cartilage destruc tion 3 . In Alzheimer's disease, neurotoxicity is associated with activated microglial cells adjacent to βamyloid containing plaques that generate ROS in addition to proinflammatory cytokines 4 . Sterile inflammation is also an important component of atherosclerosis, as engulfment of cholesterol crystals by macrophages leads to the activation and recruitment of inflamma tory cells, endothelial cell dysfunction and plaque form ation 5 . Finally, immune cell infiltration in the absence of microorganisms is also characteristic of tumours, and these cells can influence the growth and progres sion of cancer 6 . Thus, understanding the mechanisms of sterile inflammation is important for devising treatment strategies against various human diseases.
As the inflammation induced in response to sterile cell death or injury is similar to that observed during microbial infection, host receptors that mediate the immune response to microorganisms may be involved in the activation of sterile inflammation. In the case of infection, the mechanisms by which the inflam matory response is initiated have been well studied. There are several classes of receptors that are impor tant for sensing microorganisms and for the subse quent induction of proinflammatory responses (for a
Myocardial infarction
An episode of acute cardiac ischaemia that leads to death of heart muscle cells. It is usually caused by a thrombotic atherosclerotic plaque.
Atherosclerosis
A chronic disorder of the arterial wall characterized by endothelial cell damage that gradually induces deposits of cholesterol, cellular debris, calcium and other substances. These deposits finally lead to plaque formation and arterial stiffness.
Necrosis
A form of cell death that frequently results from toxic injury, hypoxia or stress. Necrosis involves the loss of cell integrity and the release of cell contents into the interstitium. This form of cell death usually occurs together with inflammation. Depending on the context, the self antigens that are released by necrosis can become immunogenic.
review, see Ref. 7) . These have been collectively termed pattern recognition receptors (PRRs). These germline encoded PRRs sense conserved structural moieties that are found in microorganisms and are often called pathogenassociated molecular patterns (PAMPs). Five classes of PRRs have been identified to date: Tolllike receptors (TLRs), which are transmembrane proteins located at the cell surface or in endosomes; NODlike receptors (NLRs), which are located in the cytoplasm; RIGIlike receptors (RLRs), which are also located intracellularly and are primarily involved in antiviral responses; Ctype lectin receptors (CLRs), which are transmembrane receptors that are characterized by the presence of a carbohydratebinding domain; and absence in melanoma 2 (AIM2)like receptors, which are characterized by the presence of a pyrin domain and a DNAbinding HIN domain involved in the detection of intracellular microbial DNA 8 . Following ligand rec ognition or cellular disruption, these receptors activate downstream signalling pathways, such as the nuclear factorκb (NFκb), mitogenactivated protein kinase (MAPK) and type I interferon pathways, which result in the upregulation of proinflammatory cytokines and chemokines that are important in inflammatory and antimicrobial responses.
It is now evident that PRRs also recognize non infectious material that can cause tissue damage and endogenous molecules that are released during cellu lar injury (TABle 1) . These endogenous molecules have been termed damageassociated molecular patterns (DAMPs), as these hostderived nonmicrobial stimuli are released following tissue injury or cell death and have similar functions as PAMPs in terms of their abil ity to activate proinflammatory pathways. Here, we discuss the nature of these instigators of inflammation in the absence of infection, the potential mechanisms by which they are recognized by the host to activate inflammatory pathways and the implications for disease management.
DAMPs: indicators of tissue injury
A common feature of DAMPs is that they are endog enous factors that are normally sequestered intracel lularly and are therefore hidden from recognition by the immune system under normal physiological condi tions. However, under conditions of cellular stress or injury, these molecules can then be released into the extracellular environment by dying cells and trigger inflammation under sterile conditions. The type of cell death notably affects its immunogenicity and ability to release immunostimulatory DAMPs. However, in gen eral, DAMPs can be construed as signals of a potential danger to the host 9
. Necrosis usually occurs under conditions of extreme damage (for example, ischaemia or trauma) when apoptosis fails to occur. An important consequence of necrotic cell death is the loss of plasma membrane integrity, thereby allowing escape of intra cellular material from the cell. Prototypical DAMPs derived from necrotic cells include the chromatin associated protein high-mobility group box 1 (HMGb1) 10 , heat shock proteins (HSPs) 11 , and purine metabolites, such as ATP 12 and uric acid 13 (TABle 1) . In addition to DAMPs from an intracellular source, there are also extracellularly located DAMPs. These are typically released by extracellular matrix degradation during tissue injury. extracellular matrix fragments, such as hyaluronan, heparan sulphate and biglycan, are gener ated as a result of proteolysis by enzymes released from dying cells or by proteases activated to promote tissue repair and remodelling 14 . Similarly, in addition to intra cellular molecules, intracellular stores of biologically active proinflammatory cytokines and chemokines, such as IL1α 15 and IL33 (Ref. 16) , may be released by necrotic cells. Although these factors are not conven tionally considered as DAMPs, they can mediate sterile inflammatory responses (see below).
DAMPs have been identified by their ability to induce inflammatory responses in vitro and/or in vivo when purified and by the observed reduction in inflammation when they are selectively depleted 17 . However, in addition to the concern that the stimula tory activity of some DAMPs is attributed to contami nation of purified preparations with bacterial products, important questions remain unanswered. It is unclear, for example, whether some of the DAMPs that have been identified based on their ability to stimulate proinflammatory cytokine production in vitro have a role in inducing sterile inflammation in vivo, as is the case for HSPs 11, 18 , S100 calciumbinding proteins 19 and ATP 20 . Furthermore, many DAMPs, such as HSPs and HMGb1, seem to interact with several receptors (TABle 1) and, therefore, the significance of these inter actions during sterile inflammation and disease patho genesis remains to be fully elucidated. Also unknown is the relative importance of individual DAMPs -that
Box 1 | Inflammation and wound repair
The acute inflammatory response has an integral role in normal wound healing and tissue repair to eradicate the offending agent, regenerate the parenchyma and heal any sustained damage. In response to injury that disrupts the parenchyma and causes blood vessel damage, the coagulation system is activated, which begins the initial stages of healing with the release of chemical mediators that promote vascular permeability and leukocyte adhesion and recruitment. Activated platelets also produce growth factors such as transforming growth factor-β (TGFβ) and platelet-derived growth factor (PDGF), which activate fibroblasts and act as chemoattractants for leukocytes 116 . The infiltration of leukocytes -first neutrophils, followed by macrophages -allows the removal of dead cells and cellular debris. More importantly, these cells secrete chemokines and cytokines, such as tumour necrosis factor (TNF) and interleukin-1 (IL-1), that upregulate leukocyte adhesion molecules to increase immune cell recruitment and induce the production of additional growth factors and proteases by macrophages 117 . The release of proteases including matrix metalloproteases leads to the degradation of the extracellular matrix to allow for tissue remodelling. In addition to IL-1 and TNF, growth factors and inflammatory mediators produced by macrophages, such as fibroblast growth factor (FGF), PDGF, prostaglandins and thrombospondin 1, promote new blood vessel growth, fibroblast proliferation and collagen deposition 117 . Tissue remodelling is accompanied by parenchymal regeneration or regrowth of the epithelial cell layer with resolution of the healing process. Under conditions in which complete healing does not occur, as in the setting of chronic infection or prolonged exposure to injurious agents, the inflammatory response remains unresolved. Macrophages and neutrophils persist and continue to secrete inflammatory cytokines, proteases and growth factors that lead to inappropriate tissue destruction and scarring or fibrosis.
Apoptosis
A common form of cell death that is defined by specific morphological changes and by the involvement of caspases. The morphological features include chromatin condensation, plasma membrane blebbing and DNA fragmentation into segments of ~180 base pairs. eventually, the cell breaks up into many membrane-bound 'apoptotic bodies', which are phagocytosed by neighbouring cells.
High-mobility group box 1 (HMGB1; also known as amphoterin). A nuclear protein that binds DNA in a nonsequence-specific manner and modulates transcription and chromatin remodelling by bending DNA and facilitating the binding of transcription factors and nucleosomes, respectively.
Adjuvant
A substance that stimulates the immune system to enhance the immunogenicity of antigens or vaccines and enhance antigen-specific antibody production.
is, whether they have redundant roles or whether a pre dominant DAMP (the expression of which may depend on the inciting event) triggers sterile inflammation. For example, a reduction of uric acid, which is released from dying cells and has adjuvant activity in vivo 21 , was associated with substantially reduced neutrophil recruitment in the liver after acetaminopheninduced injury in two different mouse models 13 . by contrast, in particulateinduced sterile inflammation, uric acid depletion had no effect, suggesting that uric acid may be a major proinflammatory DAMP that is specifically involved in cell deathrelated sterile inflammation 13 . However, uric acid depletion does not completely eliminate acetaminopheninduced liver inflammation or the adjuvant activity of damaged cells, which may reflect residual uric acid following depletion or redundant activities by other DAMPs.
The context of cellular injury leading to sterile inflammation may also be important. In one study, treatment of mice with HMGb1specific antibod ies during acetaminopheninduced liver necrosis ameliorated inflammatory cell recruitment 10 . However, in a peritoneal model of sterile inflammation, there was no difference between wildtype and HMGb1deficient necrotic cells in their ability to promote neutrophilic recruitment 22 . Thus, although substantial progress has been made in identifying potential DAMPs that can elicit inflammatory responses, much remains to be learnt, such as the different biological func tions of the various DAMPs during sterile inflamma tion, which would be important for identifying new therapeutic targets.
Mechanisms of sterile inflammation
Despite the growing list of sterile immune stimuli, the mechanisms by which these stimuli trigger an inflam matory response are still not fully understood. even though endogenously generated DAMPs are struc turally heterogeneous, the outcome of inflamma tory responses to these stimuli is generally uniform. Moreover, inflammatory responses during infection are very similar to responses induced by sterile stimuli, including the recruitment of neutrophils and macro phages, the production of inflammatory cytokines and chemokines, and the induction of T cellmediated adaptive immune responses 23 . This suggests that both infectious and sterile stimuli may function through common receptors and pathways. based on our cur rent understanding, we propose three, not necessar ily mutually exclusive, mechanisms by which sterile endogenous stimuli trigger inflammation: activation of PRRs by mechanisms similar to those used by micro organisms and PAMPs; release of intracellular cytokines and chemokines, such as IL1α, that activate common pathways downstream of PRRs; and direct activation by receptors that are not typically associated with microbial recognition (fIG. 1) .
Role of PRRs: recognition of endogenous DAMPs by
TLRs. There is mounting evidence that TLRs sense endogenous molecules in addition to microbial PAMPs. The possibility that mammalian TLRs recognize non microbial structures is not unexpected, because the evo lutionarily conserved Toll receptor originally identified in Drosophila melanogaster binds to the endogenous ligand Spätzle 24 . Indeed, several endogenous molecules that are released from necrotic cells or are present in the extracellular matrix have been reported to activate TLRs. These include intracellular proteins, such as HSPs, S100 proteins, uric acid, HMGb1 and endog enous nucleic acids, as well as components of the extra cellular matrix, such as hyaluronan, heparan sulphate and proteoglycans 17 .
Although several of the purified endogenous mol ecules, including HSPs, HMGb1 and uric acid, can induce the production of proinflammatory cytokines through TLR2 and/or TLR4 in vitro [25] [26] [27] , the relevance of these observations has previously been questioned because of the possibility of microbial contamination: several of these proteins, including HSPs and HMGb1, bind lipopolysaccharide (LPS), making the interpreta tion of proinflammatory responses by these molecules difficult [28] [29] [30] . because mice lacking TLR2 and TLR4 have only a slight reduction in the peritoneal inflam matory response to sterile dead cells in vivo 22 , a reason able conclusion is that TLR2-TLR4 signalling is not the main mechanism by which intracellular factors induce inflammatory responses to necrotic cell death. However, this does not exclude a role for TLR signalling in other models of sterile inflammation. For example, there is evidence for a role of TLR2 and/or TLR4 in the induc tion of cytokine and chemokine production in response to extracellular matrix components, including hyaluro nan fragments or soluble proteoglycan components, in vitro and in vivo [31] [32] [33] [34] . Tlr2 and Tlr4 doubleknockout mice exhibit impaired transepithelial recruitment of inflammatory cells and decreased survival in response to lung injury 31 . Deficiency in either TLR2 or TLR4 signalling also reduced atherosclerotic disease in mouse models [35] [36] [37] , and TLR4, specifically, has been shown to mediate inflammatory responses to free fatty acids, which are elevated in obesity and are associated with insulin resistance 38 . Similarly, TLR3 can sense endogenous RNA derived from necrotic neutrophils, which contrib utes to the inflammatory response elicited by necrosis in the bowel 39 . In the liver, which is normally devoid of microbial exposure, TLR9 has been implicated in trig gering cytokine production and hepatocyte toxicity in acetaminopheninduced injury 40 . In this model of sterile inflammation, activation of TLR9 is presum ably mediated by genomic DNA released from necrotic hepatocytes 40 . Collectively, the evidence suggests that endogenous stimuli can induce a sterile inflammatory response through TLRs, although the precise molecules that engage TLRs remain poorly defined. Furthermore, TLRs seem to function redundantly with other signal ling pathways, so the contribution of TLRs to the overall sterile inflammatory response remains unclear.
Role of PRRs: generation of IL-1β by inflammasomes.
IL1, which includes both IL1α and IL1β, is a key mediator of sterile inflammation that acts through the IL1 receptor (IL1R) 22, 41 . IL1β is a potent pro inflammatory cytokine that is produced mainly by macrophages and has many biological functions that are important in sterile inflammation, such as the upregu lation of those adhesion molecules on endothelial cells that are important for the recruitment of neutrophils and monocytes 42 and for the induction of additional proinflammatory mediators 43 . Compared with wild type mice, IL1Rdeficient mice had decreased neutro philic infiltration and inflammation in the liver after acetaminopheninduced liver injury 22 and in the lungs after exposure to silica 44 .
Box 2 | Immunogenic cell death
Sterile stimuli -specifically, damage-associated molecular patterns (DAMPs) -are generally intracellular factors that are normally hidden from recognition by the host immune system, and this 'hiding' effectively prevents pathological inflammation and autoimmunity. Sterile inflammation occurs when DAMPs are released into the extracellular environment. This occurs mostly when a cell undergoes necrotic, as opposed to apoptotic, cell death. Indeed, necrotic cells are normally immunostimulatory and lead to inflammatory cell infiltration and cytokine production 10, 18 . Apoptosis involves an orchestrated caspase signalling cascade that ultimately leads to cell rounding and shrinkage (pyknosis), chromatin condensation, non-random DNA fragmentation or laddering, plasma membrane blebbing and nuclear fragmentation (karyorrhexis). The apoptotic bodies that form can be cleared effectively by phagocytes. This death process is therefore self-contained, and immunogenic endogenous molecules are not released to a significant extent into the extracellular environment.
By contrast, necrotic cell death involves cellular and organelle swelling (oncosis) and, most importantly, rupture of the plasma membrane, resulting in the release of intracellular molecules that can elicit an inflammatory response. Reactive oxygen species production, lysosomal membrane destabilization, activation of proteases (including cathepsins) and ionic flux changes are all associated with necrosis and can activate sterile inflammatory pathways in addition to the release of DAMPs 118 . Necrosis predominates in conditions such as toxin-or ischaemia-induced injury. Although typically not associated with immunogenicity and inflammation, apoptosis can become inflammatory under conditions in which there is delayed clearance of apoptotic cells, as can occur with high levels of apoptosis, resulting in secondary necrosis with loss of plasma membrane integrity 119 . Signalling through death receptors that classically lead to apoptosis, such as FAS (also known as CD95), has also been associated with inflammatory responses, although whether this is actually correlated with the extent of apoptotic cell death is unclear 120 .
Nature Reviews | Immunology IL1β has been implicated in various nonmicrobial proinflammatory diseases. In atherosclerosis, engulfment of cholesterol by macrophages leads to IL1β production, which can stimulate the production of plateletderived growth factor, promotion of smooth muscle cell and fibroblast proliferation, arterial wall thickening and plaque formation 5, 45 . Crystalinduced arthropathies, such as gout, are associated with elevated IL1β production, which leads to joint inflammation and destruction 5 . elevated levels of IL1β are also observed in the pancreatic islet cells from patients with type 2 diabetes 46 , which is increasingly being recognized as having a strong inflammatory com ponent 47 . The secretion of IL1β by inflammatory cells is largely dependent on a multiprotein complex termed the inflammasome, of which the hallmark activity is the acti vation of caspase 1. Following activation, caspase 1 pro teolytically cleaves IL1β into its biologically active form. Caspase 1 also cleaves the IL1 family member IL18 into its active form and, therefore, IL18 may potentially be involved in sterile responses, but its relevance in sterile inflammation has not been well studied. There are sev eral inflammasomes that have been described to date, and each is named after the specific PRR contained in it. Of these inflammasomes, two have been described that can sense nonmicrobial molecules: the NLRP3 (NOD, LRR and pyrin domaincontaining 3) inflammasome and the AIM2 inflammasome.
The AIM2 inflammasome has been recently shown to recognize cytoplasmic doublestranded DNA (dsDNA) that is not necessarily microbial in origin, resulting in caspase 1 activation and IL1β secretion [48] [49] [50] . Although distinct from NLRs, AIM2 has a pyrin domain that allows it to interact with the adaptor protein ASC (apoptosis associated specklike protein containing a CARD) to form the inflammasome 50 . AIM2 has a demonstrated role in immune responses directed against both bacteria 51 and DNA viruses 52 , but it will be important to determine whether there is a physiological role for AIM2 in sterile inflammation, especially in autoimmune diseases such as systemic lupus erythematosus, which is associated with elevated circulating levels of dsDNA.
Our understanding of how IL1β production is induced during sterile inflammation has been advanced by studies of the NLRP3 inflammasome. NRLP3 was initially identified as an important mediator of chronic inflammation owing to its association with auto inflammatory disorders
. Since then, NLRP3 has been implicated in various sterile inflammatory diseases. NLRP3 signalling has been shown to involve at least two steps, the first involving PRR or cytokine dependent transcriptional upregulation of NLRP3 and the second involving activation of the NLRP3 inflam masome, which leads to IL1β production 53, 54 
A unique feature of NLRP3 is its ability to sense various structurally diverse stimuli. Therefore, it is posited that NLRP3 does not recognize each stimulus individually, but senses a common downstream event. NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals 55 , cholesterol crystals and βamyloid fibrils 56 . Consistently, in mouse models of sterile injury, such as gout, asbestosis and silicosis, NLRP3deficient mice exhibited decreased inflammation with reduced levels of tissue infiltration by neutrophils or macrophages 55, 57, 58 . Lowdensity lipo protein (LDL) receptordeficient mice, which are prone to developing atherosclerotic lesions, had lower IL1β levels, smaller atherosclerotic lesions and less neutro philic infiltration than wildtype mice when lethally irradiated and infused with NLRP3deficient bone mar row 59 . NLRP3deficient mice were also less susceptible to renal ischaemia-reperfusion injuries induced by bilat eral renal artery ligation and to acetaminopheninduced hepatotoxicity 40, 60 . A potential role for NLRP3 in pro moting elevated levels of IL1β in type 2 diabetes was also implied by the observation of NLRP3dependent IL1β secretion by mouse bone marrowderived macro phages and dendritic cells in response to islet amyloid polypeptide (IAPP), which is deposited in the pancreas and associated with loss of βcell function in type 2 dia betes 61 . Interestingly, the antidiabetic drug glyburide (Glibenclamide; Roche/SanofiAventis) has been shown to block glucosemediated secretion of IL1β by mouse pancreatic islets 62 , as well as IL1β production by macro phages in response to IAPP 61 , and NLRP3deficient mice were more glucose tolerant than wildtype mice 62 . However, whether NLRP3 is directly involved in the pathogenesis of type 2 diabetes in humans remains to be determined. Regardless, understanding how NLRP3 senses diverse sterile stimuli is important for under standing the pathogenesis of possibly many sterile inflammatory disorders and for identifying potential therapeutic targets. There are three main pathways that have been proposed to mediate sterile activation of NLRP3 (fIG. 2) . These can be categorized as ATP, lysosomal damage or ROSmediated activation.
In vitro, robust activation of the NLRP3 inflam masome in phagocytic cells that were pretreated with microbial products or cytokines such as TNF is depend ent on the presence of ATP 20 . However, the amounts of ATP necessary for NLRP3mediated caspase 1 activa tion to be detected in macrophages in vitro are greater than physiological concentrations 63 and, therefore, the relevance of this pathway in vivo is uncertain. ATP binds to purinergic receptor P2X7 (P2RX7), which leads to the opening of an ATPgated cation channel that induces K + efflux and the formation of a large pore mediated by the hemichannel protein pannexin 1 (RefS 64,65). Thus, it has been suggested that NLRP3 senses intracellular K + depletion, which may act as a surrogate marker of cellular injury that is sensed by NLRP3. Consistently, inhibition of K + efflux by high extracellular K + concen trations prevents NLRP3dependent caspase 1 activation in response to ATP, asbestos, silica and MSU crystals 58, 66 . Also, necrotic cells can activate NLRP3, which is partly dependent on actively respiring mitochondria and the physiological release of ATP 60 . However, IL1β secre tion was only partially dependent on P2RX7, suggesting that the release of ATP may be only one mechanism by which necrotic cells can activate NLRP3. It is probable that additional factors besides ATP have a role 60 .
Box 3 | Role of NLRP3 in autoinflammatory syndromes
Autoinflammatory syndromes are a group of rare monogenic inherited disorders that are characterized by episodic occurrences of fever, sterile inflammation and other more variable inflammatory manifestations in the absence of clinical and laboratory markers of autoimmunity or infection. These syndromes include familial cold autoinflammatory syndrome, Muckle-Wells syndrome and neonatal-onset multisystemic inflammatory disease (NOMID; also known as CINCA syndrome) and are caused by missense mutations in the nucleotide-binding oligomerization domain (NOD)-like receptor family member NLRP3 (NOD-, LRR-and pyrin domain-containing 3; also known as cryopyrin). Clinical features of these dominantly inherited disorders, which are commonly referred as cryopyrin-associated periodic syndromes, include recurring episodes of fever, urticarial skin rash and arthropathy. These diseaseasssociated missense NLRP3 mutations result in enhanced activation of caspase 1 and secretion of interleukin-1β (IL-1β) by causing constitutive activation of the NLRP3 inflammasome. Notably, treatment of these patients with an IL-1 receptor antagonist or IL-1β-specific blocking antibody reverses clinical symptoms, which suggests a cause-effect relationship between IL-1β production and the development of disease.
Box 4 | NLRP3 activation
The assembly and activation of the NLRP3 (NOD-, LRR-and pyrin domain-containing 3) inflammasome results in the cleavage of pro-caspase 1 to its active form, which in turn, cleaves pro-interleukin-1β (pro-IL-1β) and pro-IL-18 into their mature, biologically active forms. In vitro studies have led to a model of NLRP3-mediated IL-1β production that requires two separate signals. The first signal is the nuclear factor-κB (NF-κB)-dependent transcription of pro-IL-1β and NLRP3, either through the activation of Toll-like receptors (TLRs) or nucleotide-binding oligomerization domain 2 (NOD2), and therefore, in vitro, this signal can be provided by various TLR or NOD2 agonists, such as lipopolysaccharide 20, 53, 121 . In the case of sterile inflammation, certain cytokines that induce NF-κB, such as tumour necrosis factor or IL-1, can provide the first signal for NLRP3 activation 54 . In addition, during sterile inflammation, endogenous molecules that signal through TLRs, such as low-density lipoprotein, may be the first signal to prime the activation of the NLRP3 inflammasome, resulting in cooperative signalling through separate pathways 14, 40, 61, 105 . The second signal is provided by stimuli that specifically activate NLRP3 and leads to caspase 1 activation. In vitro, this second signal is typically provided by the addition of ATP or certain bacterial toxins, which results in pore formation and K + depletion that may be sensed by NLRP3, leading to caspase 1 activation and pro-IL-1β cleavage. As intracellular pro-IL-1β levels are usually low, the first signal has been considered to be a 'priming' event to allow for subsequent NLRP3 activation and IL-1β release, which otherwise could not occur. The two step model would allow for an additional level of regulation of caspase 1 activation. Nature Reviews | Immunology 
NADPH oxidase
An enzyme system that consists of several cytoplasmic and membrane-bound subunits. The complex is assembled in activated phagocytic cells mainly on phagolysosomal membranes. NADPH oxidase uses electrons from NADPH to reduce molecular oxygen to form superoxide anions. Superoxide anions are enzymatically converted to hydrogen peroxide, which is converted by myeloperoxidase to hypochloric acid, a highly toxic and microbicidal agent.
P2RX7dependent pore formation is not a prerequi site for NLRP3 activation by all stimuli. Urate and choles terol crystals, as well as sterile particulates, for example, can bypass the requirement for ATP and P2RX7 for IL1β production 55, 59 . For these sterile particulates to activate NLRP3, they must be internalized, as block ade of endocytosis by the actindepolymerizing drug cytochalasin D inhibited NLRP3dependent IL1β pro duction 58, 59 . Importantly, NLRP3dependent caspase 1 activation was associated with destabilization of the lyso somal membrane and activation of lysosomal proteases (specifically, cathepsin b) 44 . Lysosomal damage can occur during cellular injury and necrosis, and has also been associated with other sterile activators of NLRP3, such as cholesterol 59 and silica crystals 44 . Therefore, it is possible that divergent upstream danger signals that are sensed by NLRP3 may converge on lysosomal damage and cathepsin b activation. evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibi tion or genetic depletion of cathepsin b results in inhi bition of caspase 1 activation, although this inhibition was only partial 44, 56, 59 . However, cathepsin bdeficient macrophages have no impairment in IL1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica 44, 56, 59, 67 . Furthermore, there is only partial inhibition of the neutrophil infiltration and IL1β production associated with sterile inflammation in response to cholesterol crystals 44, 56, 59, 67 . An additional damage signal that has been associ ated with NLRP3 stimulation and caspase 1 activation is ROS. During sterile inflammation, the production of ROS by neutrophils (for example, through an oxida tive burst) is important for the destruction of pathogens but, during excessive cellular stress, high levels of ROS can lead to oxidative stress with ensuing cell death and necrosis. ROS levels can be controlled by neutralization by enzymes with antioxidant activities. Therefore, the detrimental effect of ROS during sterile inflammation depends on the balance between ROS producers and ROS inactivators. Silica 58, 68 , asbestos 57 and ATP 69 have all been associated with ROS production, and ROS inhibi tion in vitro resulted in impairment of caspase 1 activation and IL1β production by these stimuli 57, 58, 69 . How ROS production is sensed by NLRP3 is unknown, but it was recently shown in one study that NLRP3 interacts in a ROSdependent manner with thioredoxininteracting protein (TXNIP), which dissociates from the antioxi dant enzyme thioredoxin during oxidative stress 62 . In this study, TXNIPdeficient mice had impaired IL1β produc tion and neutrophil influx after intraperitoneal injection of MSU crystals, and TXNIPdeficient macrophages had decreased IL1β production in response to a range of known NLRP3 activators, including MSU crystals, silica, and ATP
62
. Thus, the sensing of ROS may be a unifying mechanism by which NLRP3 senses its various activa tors. However, the role of TXNIP and ROS in NLRP3 activation has been challenged. In a separate study, no differences in IL1β secretion were observed between wildtype and TXNIPdeficient bone marrowderived macrophages in response to several NLRP3 stimuli, including MSU crystals and ATP 61 . Furthermore, mouse macrophages that are deficient in p22 phox (L. Franchi and G.N., unpublished observations) or the Gp91 phox subunit of NADPH oxidase cytochrome b, which is a major genera tor of ROS in the cell, had normal, rather than decreased, levels of caspase 1 activation in response to ATP, silica or MSU crystals 44 . Thus, the relevance of ROS generation in NLRP3 activation in vivo remains unclear. Collectively, there is still controversy regarding the roles of the indi vidual model pathways for NLRP3 activation, and it remains to be determined whether there is a common mechanism by which numerous heterogeneous stimuli converge on NLRP3.
Role of PRRs: an emerging role for CLRs. CLRs are an increasingly recognized category of PRRs that are important in host defence. This class of PRRs contains a carbohydratebinding domain that recognizes carbo hydrates on viruses, bacteria and fungi. In general, the ligands of these CLRs are unknown 70 . Stimulation of CLRs typically results in the induction of signalling (NOD-, LRR-and pyrin domain-containing 3) inflammasome has been associated with three separate phenomena. ATP can bind to purinergic receptor P2X7 (P2RX7), which then opens a cation channel and a large pore through pannexin 1 that, in turn, can lead to ionic fluxes, including intracellular K + depletion, and other events that are poorly understood. Endocytosis of sterile particulates, such as silica, asbestos and cholesterol crystals, results in lysosomal damage and membrane destabilization, leading to activation of the protease cathepsin B. The generation of reactive oxygen species (ROS) during cellular stress or death has been associated with NLRP3 activation, although the role of ROS in NLRP3 activation remains controversial. DAMPs, damage-associated molecular patterns; IL-1β, interleukin-1β.
pathways that, in some cases, can synergize with TLR signalling pathways to upregulate cytokine and chemo kine production. In antigenpresenting cells, they are involved in antigen uptake and trafficking for antigen presentation 71 . Although their primary importance is in host defence against pathogens, CLRs can sense necrotic cell death 72 . In particular, Ctype lectin 4e (CLeC4e; also known as MINCLe) can detect the DAMP spliceosomeassociated protein 130 (SAP130), which is a component of a small nuclear ribonucleo protein that can be released by necrotic but not apoptotic cells, resulting in upregulation of proinflammatory media tors such as CXCchemokine ligand 2 (CXCL2) and in neutrophil recruitment 73 . In a model of high levels of cell death in the thymus by wholebody irradiation, CXCL2 production by thymic macrophages, as well as neutrophil infiltration into the thymus, was sig nificantly suppressed in mice treated with a blocking antibody to CLeC4e 73 . whether CLeC4e contributes to sterile inflammationrelated diseases is unknown. Interestingly, Clec4e mRNA is upregulated in patients with rheumatoid arthritis 73, 74 . CLeC9A (also known as DNGR1), which is expressed by CD8α + dendritic cells, is also involved in the recognition of necrotic cells. CLeC9A has been shown to recognize necrotic cells and induce the cross presentation of dead cellassociated antigens to CD8 + T cells. Therefore, it may be involved in regulating sterile immune responses, although the specific ligand recognized in this case is still unknown 73, 75 . Similar to CLeC4e, the ability of CLeC9A to recognize necrotic cells makes it a potential receptor that is important for sterile inflammatory responses. Determining whether CLeC9A contributes to sterile inflammation in vivo should be possible, as transgenic mice deficient in this receptor have been made 75 .
Release of intracellular cytokines. The passive release of biologically active cytokines during sterile injury associated cell death is an important mechanism to alert the immune system of tissue damage and to initiate the healing response. There is evidence that the passive release of cytokines during sterile cell injury has a role in disease. Two cytokines of the IL1 family, IL1α and IL33, are particularly relevant. In the case of IL1α, its release from injured endothelial cells promotes allogeneic T cell infiltration in a mouse-human chimeric model of artery allograft rejection 76 . In addition, IL1α released during hepatocyte necrosis contributes to carcinogen induced liver tumorigenesis in mice 77 . Unlike its related family members IL1β and IL18, IL1α is synthesized as a biologically active cytokine in its fulllength precur sor form and does not require processing for signalling through IL1R 78, 79 . when cells die by necrosis, such as during injury, this precursor form of IL1α is released, leading to activation of its cognate receptor and rapid recruitment of inflammatory cells into the surrounding injured tissue 22, 78 . This is in contrast with apoptotic cells, in which IL1α is sequestered intracellularly 78 , or with intact cells, in which the secretion of mature IL1α is partially dependent on caspase 1 activity [80] [81] [82] .
The mechanism by which necrotic cells and IL1α induce sterile inflammation remains poorly understood. Using a model of peritonitis triggered by necrotic cells, IL1α was shown to be important for the recruitment of neutrophils, which was caspase 1 independent, and this response was impaired in mice lacking IL1R expression by nonmyeloid cells 22 . Subsequently, it was shown that IL1α released by necrotic cells was crucial for the pro duction of CXCL1, which recruits neutrophils, by non haematopoietic cells such as mesothelial cells 15 . However, the mechanism by which necrotic cells induce acute inflammatory responses seems to be more complex in vivo. For example, necrotic dendritic cells, but not necrotic macrophages, heart cells or liver cells, rely on IL1α to recruit neutrophils, at least in a peritonitis model 41 . In the case of necrotic liver tissue, IL1α and IL1β derived from resident macrophages, but not the necrotic cells themselves, seem to have a crucial role in eliciting the neutrophilic response 41 . Thus, the release of IL1α from certain cells, such as dendritic cells, contributes to sterile inflammation, but macrophages seem to be the primary sentinel cells that mediate the sensing of necrotic cells through the production of mature IL1α and IL1β
41
. The mechanism by which resident macro phages produce mature IL1α and IL1β in response to necrotic cells to mediate neutrophilic recruitment remains unclear, but it is caspase 1 independent 22 , suggesting that in the case of IL1β other proteases may be responsible for cleaving proIL1β to its active form 83, 84 . These studies suggest that the precursor form of IL1α that is released by necrotic cells contributes to the initial neutrophilic response, but resident macrophages are the main source of mature IL1α and IL1β, which are needed for cell deathinduced sterile inflammation (fIG. 3) . Locally produced IL1 then mediates neutrophil recruitment within the peritoneal cavity through IL1R signalling and induction of CXCL1 production (fIG. 3) .
Similar to IL1α, IL33 is active as a precursor pro tein. extracellular IL33 that is released during necrosis also functions as an alarmin to alert cells, such as mast cells and other innate immune cells, to tissue damage 85, 86 . Although it was initially thought that the IL33 precur sor was processed by caspase 1 to produce biologically active IL33, it is now clear that its processing by the executioner caspases caspase 3 and caspase 7 during apoptosis inactivates IL33 (RefS 85, 86) . Thus, IL33, which is expressed at high levels by endothelial cells and some epithelial cells, is expected to be active when it is released during necrosis, but not apoptosis, which is asso ciated with executioner caspase activation. IL33 is highly expressed within endothelial cells in the synovium of patients with rheumatoid arthritis 87 , and IL33deficient mice have reduced neutrophil migration in an experi mental model of rheumatoid arthritis 88 , but the actual role of this cytokine in the pathogenesis of rheumatoid arthritis or other sterile inflammatory diseases remains to be determined. Collectively, the evidence suggests that the precursor forms of IL1α and IL33 (both of which are biologically active) are preferentially released dur ing necrosis to alert the immune system to cell damage, leading to the initiation of the healing response. [89] [90] [91] . It detects advanced glycation endproducts (AGes) that arise from nonenzymatic glycation and oxidation of proteins and lipids. These products can accumulate under conditions of high oxidant stress and are found at elevated levels in chronic inflammatory disease states such as type 1 diabetes 92 . In addition to AGes, RAGe also recognizes HMGb1 93 and the S100 family members 19 , which are released dur ing cellular stress and necrotic cell death, and βamyloid 94 , the accumulation of which is pathogenic in Alzheimer's disease. Activation of RAGe by its ligands results in the upregulation of several inflammatory signal ling pathways, including, but not limited to, NFκb, phospho inositide 3kinase, Janus kinase (JAK)-signal transducer and activator of transcription (STAT) and MAPK signalling pathways, which lead to induction of proinflammatory cytokines such as TNF 19, 91, 95, 96 . The mechanism by which RAGe activates these pro inflammatory signalling pathways is unclear. The protein contains no obvious signalling domains 90 , although extracellular signalregulated kinase (eRK) was shown to directly interact with the cytoplasmic tail of RAGe 97 . In certain cases, RAGe may transduce signals by acting cooperatively with TLRs. Specifically, HMGb1bound DNA can form a complex with TLR9 and RAGe to induce proinflammatory cytokines 98 , which may be important for promoting inflammation in patients with systemic lupus erythematosus who have elevated cir culating levels of DNAcontaining immune complexes. The mechanistic detail of RAGe signalling and the importance of its various ligands in disease pathology continue to be areas of investigation.
RAGe has been implicated in both diabetes and obesityrelated atherosclerosis using apolipoprotein e (APOe)deficient mice, which are susceptible to devel oping atherosclerosis 99, 100 . Furthermore, blockade of RAGe by using a soluble competitive inhibitor sup pressed diabetesassociated atherosclerosis in mouse models 92 . Apoe -/-Rage -/-mice also exhibited a reduc tion in atherosclerosis 101 , as shown by a reduction in both atherosclerotic plaque formation and production of proinflammatory mediators within the aorta. In addition, the binding of βamyloid to RAGe results in activated microglial cells 94 , and RAGe expression by microglial cells contributed to neuroinflammation in a mouse model of Alzheimer's disease 89 . whether RAGe has a direct role in the pathogenesis of these diseases in humans and what pathways are specifically activated remain to be elucidated. Several other nonPRRs have been shown to inter act with certain DAMPs, although their precise roles during sterile inflammation in vivo have not been veri fied. As in the case of TLR9 and RAGe, some of these receptors engage TLRs to form coreceptor complexes, which then induce inflammatory responses through TLRdependent pathways. Hyaluronan fragments, for example, can signal through CD44, leading to MAPK activation 102 . Hyaluronan is also directly recognized by TLR2 and TLR4, and this interaction was shown to have a role in mediating inflammatory responses in a mouse model of sterile bleomycininduced lung injury 102 . How CD44 signalling contributes to sterile inflammation is unclear, but it has been shown to phys ically interact with TLR4 in vitro and function as an accessory molecule for TLR4 signalling in response to hyaluronan 102, 103 . Similarly, CD36 is a scavenger recep tor that binds oxidized LDL and βamyloid, which are associated with sterile inflammation related to athero sclerosis and Alzheimer's disease, respectively. CD36 mediates heterodimer formation of TLR4 and TLR6 (Ref. 104) , and this coreceptor complex upregulates the production of chemokines and cytokines such as pro IL1β through the activation of NFκb. Induction of NFκb signalling through this coreceptor complex to produce IL1β may serve as a priming event for subse quent NLRP3 activation 105 (the first signal; see BOX 1) or provide additional signals to mediate inflammation in atherosclerosis and Alzheimer's disease.
It has also been shown that DAMPspecific recep tors can negatively regulate inflammatory responses. Specifically, CD24, which can bind to both HMGb1 and HSPs, negatively regulates sterile inflammatory -1R) , to secrete the chemokine CXC-chemokine ligand 1 (CXCL1). In addition, IL-1α can stimulate resident macrophages to produce additional IL-1α and IL-1β through a caspase 1-independent mechanism that further boosts CXCL1 secretion. In turn, CXCL1 functions through CXC-chemokine receptor 2 (CXCR2) on neutrophils to recruit them to the site of injury. This figure is based on published studies using a peritoneal model of sterile inflammation 15, 22, 41 . responses. CD24mediated inhibition was associated with increased proinflammatory cytokine production by HMGb1 and decreased survival following aceta minopheninduced liver injury 106 . This may provide one mechanism by which the host immune system can modulate responses to DAMPs and distinguish DAMPs from PAMPs 107 . whether there are other examples of this phenomenon remains to be determined. Thus, although there are nonPRRs that can sense sterile stimuli, most notably RAGe, whether these receptors have a primary or secondary role (for example through regulation of TLR responses) in sterile inflammation and their relevance in the pathogenesis of human disease remain unknown.
Implications for therapy
Given the crucial role for IL1 in sterile inflamma tory responses, blockade of IL1R has been tested as a therapeutic target for sterile inflammatory disorders in humans. Promising results have been obtained with the use of IL1β blockade using anakinra (Kineret; Amgen/ biovitrum), a recombinant IL1R antagonist. Anakinra was shown to be highly effective in the treatment of patients with gout who could not tolerate or did not respond to previous therapy 108 . Although the clini cal study was small, with only ten patients evaluated, all ten patients treated with anakinra had significant relief from symptoms 108 . However, the effect of IL1R antagonism in other inflammatory joint diseases, such as osteoarthritis and rheumatoid arthritis, has not been as promising, with little or no clinical benefit shown in human clinical trials 43 . A benefit for anakinra was also shown in a small, randomized trial of 70 patients with type 2 diabetes 109 . Those treated with anakinra had improved glucose lev els and reduced systemic inflammation, as suggested by lower circulating levels of inflammatory markers, such as IL6 and Creactive protein. This treatment approach for type 2 diabetes is promising, as the improvement in levels of glucose and inflammatory markers was longlasting 110 . However, the clinical study was still small and was not designed to determine opti mal dosing, duration of use or longterm outcomes in disease control.
Chronic inflammation is also important for carcino genesis, as proinflammatory cytokines, including IL1β, can be tumour promoting 6, 111 . Thus, IL1R may also be a potential target for the treatment of patients with cancer. However, inflammatory responses are equally important for mounting an effective antitumour response against chemotherapyinduced, immunogenic tumour cell death. Dying tumour cells release ATP and, indeed, the ability of dendritic cells to prime tumourspecific T cells required NLRP3 and P2RX7 (Ref. 112) . Furthermore, chemotherapytreated tumour cells injected into wild type mice inhibited tumour development when the mice were rechallenged with tumour cells, but this effect was abrogated in NLRP3deficient and P2RX7deficient mice 112 , suggesting that NLRP3mediated IL1β produc tion through the ATP-P2RX7 pathway is important for immune surveillance against tumours. Consistently, a lossoffunction P2RX7 allele was also associated with poorer prognosis (decreased metastasisfree survival) in earlystage breast cancer patients treated with chemo therapy 112 . Thus, an approach to treating patients with cancer hinges on an improved understanding of how to balance the tumoursuppressive and tumourpromoting functions of IL1β.
Similarly, as TLRs also mediate sterile inflam mation, they could be another potential therapeutic target. Mice deficient in both TLR2 and TLR4 or in myeloid differentiation primaryresponse protein 88 (MYD88), an adaptor protein for TLR and IL1R sig nalling, were protected against bleomycininduced lung injury related to the generation of hyaluronan fragments, and administration of a hyaluronan blocking peptide to wildtype mice provided similar, although incomplete, protection 31 . TLR signalling is also implicated in the pathogenesis of atherosclerotic disease [35] [36] [37] . Furthermore, it was shown that TLR2 signalling by the endogenous extracellular matrix derived proteoglycan versican can promote tumour metastasis 34 . However, as TLR signalling is important for tissue repair 113, 114 , caution must also be taken in devising a therapeutic strategy against TLRmediated sterile inflammation. Indeed, mice deficient in TLR2 and TLR4 expression had increased mortality in response to hypoxiainduced lung injury, which was associated with decreased integrity of the lung epi thelium 31 . TLR signalling during sterile inflammation in the tumour microenvironment also has important clinical implications. TLR4 signalling was found to be important for dendritic cellmediated crosspresentation of tumour antigens from dying, chemotherapytreated tumour cells and involved HMGb1 release from the dying cells 115 . The clinical importance of this finding was suggested by the fact that, in earlystage breast cancer patients who were treated with chemotherapy, lower metastasisfree survival was associated with a TLR4 polymorphism that affects binding of HMGb1 to TLR4 (Ref. 115) . Thus, as inflammation is impor tant not only in disease pathogenesis but also in tis sue repair mechanisms and immune surveillance, challenges remain in identifying optimal targets and appropriate contexts for the treatment of sterile inflammatory disorders.
Conclusion
Much progress has been made in identifying some of the triggers of sterile inflammation. Many questions remain, including the relative importance of the dif ferent DAMPs in their biological activity, whether they differentially activate downstream signalling pathways and the molecular basis for their recog nition. whether there are additional unidentified endogenous DAMPs that may be implicated in disease is also unknown. Finally, further studies are needed to understand how the different inflammatory signal ling pathways (mediated by TLRs, inflammasomes and IL1R) interact to mediate the sterile inflamma tory response and how they may be modulated for the benefit of the host.
